Repigmentation of Tenacious Vitiligo on Apremilast
Vitiligo is a common pigment disorder characterized by acquired loss of function or absence of melanocytes, leading to distinct areas of depigmentation. Physical exam reveals sharply demarcated, depigmented macules or patches on otherwise normal skin. Vitiligo can present at any age, in any skin col...
Saved in:
Main Authors: | Sara B. Huff, Lorie D. Gottwald |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Case Reports in Dermatological Medicine |
Online Access: | http://dx.doi.org/10.1155/2017/2386234 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vitiligo
by: Monisha Gupta
Published: (2024-12-01) -
Phototherapy in vitiligo
by: Anuradha Bishnoi, et al.
Published: (2024-12-01) -
Gender-related Therapeutical Response to Apremilast: New Insights in a Tailored Management of Psoriasis
by: Emanuele Trovato, et al.
Published: (2025-01-01) -
Assessment of The Impact of Apremilast on Levels of IL-17, IL-23, and Lipids in Obese Psoriatic Patient
by: Haitham M. Saad, et al.
Published: (2024-12-01) -
Advances in the etiopathogenesis of vitiligo
by: Thomas Mathew, et al.
Published: (2024-12-01)